IGM-55.5

N/A

Report date: 2024/11/13 18:01:28

Base Information

Drug NameIGM-55.5

Drug Alias NameIGM-55.5

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLeukemia, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIgm Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLeukemia, B-Cell

Inactive IndicationsN/A

ATC CodeN/A